Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
13
PharmaCompass offers a list of Sodium Nitroprusside API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Nitroprusside manufacturer or Sodium Nitroprusside supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Nitroprusside manufacturer or Sodium Nitroprusside supplier.
PharmaCompass also assists you with knowing the Sodium Nitroprusside API Price utilized in the formulation of products. Sodium Nitroprusside API Price is not always fixed or binding as the Sodium Nitroprusside Price is obtained through a variety of data sources. The Sodium Nitroprusside Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nitropress manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nitropress, including repackagers and relabelers. The FDA regulates Nitropress manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nitropress API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nitropress manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nitropress supplier is an individual or a company that provides Nitropress active pharmaceutical ingredient (API) or Nitropress finished formulations upon request. The Nitropress suppliers may include Nitropress API manufacturers, exporters, distributors and traders.
click here to find a list of Nitropress suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nitropress DMF (Drug Master File) is a document detailing the whole manufacturing process of Nitropress active pharmaceutical ingredient (API) in detail. Different forms of Nitropress DMFs exist exist since differing nations have different regulations, such as Nitropress USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nitropress DMF submitted to regulatory agencies in the US is known as a USDMF. Nitropress USDMF includes data on Nitropress's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nitropress USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nitropress suppliers with USDMF on PharmaCompass.
A Nitropress CEP of the European Pharmacopoeia monograph is often referred to as a Nitropress Certificate of Suitability (COS). The purpose of a Nitropress CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Nitropress EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Nitropress to their clients by showing that a Nitropress CEP has been issued for it. The manufacturer submits a Nitropress CEP (COS) as part of the market authorization procedure, and it takes on the role of a Nitropress CEP holder for the record. Additionally, the data presented in the Nitropress CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Nitropress DMF.
A Nitropress CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Nitropress CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Nitropress suppliers with CEP (COS) on PharmaCompass.
A Nitropress written confirmation (Nitropress WC) is an official document issued by a regulatory agency to a Nitropress manufacturer, verifying that the manufacturing facility of a Nitropress active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nitropress APIs or Nitropress finished pharmaceutical products to another nation, regulatory agencies frequently require a Nitropress WC (written confirmation) as part of the regulatory process.
click here to find a list of Nitropress suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nitropress as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nitropress API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nitropress as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nitropress and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nitropress NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nitropress suppliers with NDC on PharmaCompass.
Nitropress Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nitropress GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nitropress GMP manufacturer or Nitropress GMP API supplier for your needs.
A Nitropress CoA (Certificate of Analysis) is a formal document that attests to Nitropress's compliance with Nitropress specifications and serves as a tool for batch-level quality control.
Nitropress CoA mostly includes findings from lab analyses of a specific batch. For each Nitropress CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nitropress may be tested according to a variety of international standards, such as European Pharmacopoeia (Nitropress EP), Nitropress JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nitropress USP).
